A major clinical trial, led by experts at the University of Nottingham working in partnership with several universities and NHS hospitals, has found that interrupting the treatment of vulnerable people on long-term immune-suppressing medicines for two weeks after a COVID-19 booster vaccination doubles their…
in Health
Interrupting treatment of patients on immune-suppressing medicine doubles antibody response to COVID-19 booster
